Object

Funding for basic, translational or clinical research on malignant lymphoma, malignant lymphoid neoplasia and related malignant blood diseases (particularly lymphoid disorders). Projects will be considered that enhance our understanding of the origin and biology of these disorders as well as projects that furnish insights or develop tools that will advance the treatment.

Funding

Applications for funding for personnel and materials/infrastructure have a maximum of 1.5 M€

Duration

Maximum 4 years.

Any promising research project that is relevant, innovative, impactful, and of high quality is eligible for funding.

Applications from individual researchers or research groups are welcome. All (inter)national researchers working on basic, translational and clinical research on lymphoma are invited to submit a research proposal. In particular, collaborative research proposals from various scientific groups (national and/or international) with complementing expertise are encouraged to apply for a research grant.

The main applicant must be employed by a university, university hospital or research organization.

Commercial parties are not eligible for funding.

There will be a two-stage submission procedure for applications:

- Pre-proposals: deadline 14 July 2020.

- Full proposals: for selected consortia only. Deadline November 27, 2020

In case of interest, please contact with FSJD Research's Department.